Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines

I. M. Anderson, I. N. Ferrier, R. C. Baldwin, P. J. Cowen, L. Howard, G. Lewis, K. Matthews, R. H. McAllister-Williams, R. C. Peveler, J. Scott, A. Tylee, British Assoc Psychopharmacology

    Research output: Contribution to journalReview article

    373 Citations (Scopus)

    Abstract

    A revision of the 2000 British Association for Psychopharmacology evidence-based guidelines for treating depressive disorders with antidepressants was undertaken to incorporate new evidence and to update the recommendations where appropriate. A consensus meeting involving experts in depressive disorders and their management was held in May 2006. Key areas in treating depression were reviewed, and the strength of evidence and clinical implications were considered. The guidelines were drawn up after extensive feedback from participants and interested parties. A literature review is provided, which identifies the quality of evidence to inform the recommendations, the strength of which are based on the level of evidence. These guidelines cover the nature and detection of depressive disorders, acute treatment with antidepressant drugs, choice of drug versus alternative treatment, practical issues in prescribing and management, next-step treatment, relapse prevention, treatment of relapse, and stopping treatment.

    Original languageEnglish
    Pages (from-to)343-396
    Number of pages54
    JournalJournal of Psychopharmacology
    Volume22
    Issue number4
    DOIs
    Publication statusPublished - 2008

    Keywords

    • antidepressants
    • depressive disorder
    • evidence-based guidelines
    • treatment
    • SEROTONIN-REUPTAKE INHIBITORS
    • PLACEBO-CONTROLLED TRIAL
    • RANDOMIZED CONTROLLED-TRIAL
    • TREATMENT-RESISTANT DEPRESSION
    • COGNITIVE-BEHAVIORAL THERAPY
    • TRANSCRANIAL MAGNETIC STIMULATION
    • SEASONAL AFFECTIVE-DISORDER
    • STAR-ASTERISK-D
    • VAGUS NERVE-STIMULATION
    • INDUCED SEXUAL DYSFUNCTION

    Cite this

    Anderson, I. M. ; Ferrier, I. N. ; Baldwin, R. C. ; Cowen, P. J. ; Howard, L. ; Lewis, G. ; Matthews, K. ; McAllister-Williams, R. H. ; Peveler, R. C. ; Scott, J. ; Tylee, A. ; British Assoc Psychopharmacology. / Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines. In: Journal of Psychopharmacology. 2008 ; Vol. 22, No. 4. pp. 343-396.
    @article{a538c172d92a4345b8071981bda77384,
    title = "Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines",
    abstract = "A revision of the 2000 British Association for Psychopharmacology evidence-based guidelines for treating depressive disorders with antidepressants was undertaken to incorporate new evidence and to update the recommendations where appropriate. A consensus meeting involving experts in depressive disorders and their management was held in May 2006. Key areas in treating depression were reviewed, and the strength of evidence and clinical implications were considered. The guidelines were drawn up after extensive feedback from participants and interested parties. A literature review is provided, which identifies the quality of evidence to inform the recommendations, the strength of which are based on the level of evidence. These guidelines cover the nature and detection of depressive disorders, acute treatment with antidepressant drugs, choice of drug versus alternative treatment, practical issues in prescribing and management, next-step treatment, relapse prevention, treatment of relapse, and stopping treatment.",
    keywords = "antidepressants, depressive disorder, evidence-based guidelines, treatment, SEROTONIN-REUPTAKE INHIBITORS, PLACEBO-CONTROLLED TRIAL, RANDOMIZED CONTROLLED-TRIAL, TREATMENT-RESISTANT DEPRESSION, COGNITIVE-BEHAVIORAL THERAPY, TRANSCRANIAL MAGNETIC STIMULATION, SEASONAL AFFECTIVE-DISORDER, STAR-ASTERISK-D, VAGUS NERVE-STIMULATION, INDUCED SEXUAL DYSFUNCTION",
    author = "Anderson, {I. M.} and Ferrier, {I. N.} and Baldwin, {R. C.} and Cowen, {P. J.} and L. Howard and G. Lewis and K. Matthews and McAllister-Williams, {R. H.} and Peveler, {R. C.} and J. Scott and A. Tylee and {British Assoc Psychopharmacology}",
    year = "2008",
    doi = "10.1177/0269881107088441",
    language = "English",
    volume = "22",
    pages = "343--396",
    journal = "Journal of Psychopharmacology",
    issn = "0269-8811",
    publisher = "SAGE Publications",
    number = "4",

    }

    Anderson, IM, Ferrier, IN, Baldwin, RC, Cowen, PJ, Howard, L, Lewis, G, Matthews, K, McAllister-Williams, RH, Peveler, RC, Scott, J, Tylee, A & British Assoc Psychopharmacology 2008, 'Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines', Journal of Psychopharmacology, vol. 22, no. 4, pp. 343-396. https://doi.org/10.1177/0269881107088441

    Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines. / Anderson, I. M.; Ferrier, I. N.; Baldwin, R. C.; Cowen, P. J.; Howard, L.; Lewis, G.; Matthews, K.; McAllister-Williams, R. H.; Peveler, R. C.; Scott, J.; Tylee, A.; British Assoc Psychopharmacology.

    In: Journal of Psychopharmacology, Vol. 22, No. 4, 2008, p. 343-396.

    Research output: Contribution to journalReview article

    TY - JOUR

    T1 - Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines

    AU - Anderson, I. M.

    AU - Ferrier, I. N.

    AU - Baldwin, R. C.

    AU - Cowen, P. J.

    AU - Howard, L.

    AU - Lewis, G.

    AU - Matthews, K.

    AU - McAllister-Williams, R. H.

    AU - Peveler, R. C.

    AU - Scott, J.

    AU - Tylee, A.

    AU - British Assoc Psychopharmacology

    PY - 2008

    Y1 - 2008

    N2 - A revision of the 2000 British Association for Psychopharmacology evidence-based guidelines for treating depressive disorders with antidepressants was undertaken to incorporate new evidence and to update the recommendations where appropriate. A consensus meeting involving experts in depressive disorders and their management was held in May 2006. Key areas in treating depression were reviewed, and the strength of evidence and clinical implications were considered. The guidelines were drawn up after extensive feedback from participants and interested parties. A literature review is provided, which identifies the quality of evidence to inform the recommendations, the strength of which are based on the level of evidence. These guidelines cover the nature and detection of depressive disorders, acute treatment with antidepressant drugs, choice of drug versus alternative treatment, practical issues in prescribing and management, next-step treatment, relapse prevention, treatment of relapse, and stopping treatment.

    AB - A revision of the 2000 British Association for Psychopharmacology evidence-based guidelines for treating depressive disorders with antidepressants was undertaken to incorporate new evidence and to update the recommendations where appropriate. A consensus meeting involving experts in depressive disorders and their management was held in May 2006. Key areas in treating depression were reviewed, and the strength of evidence and clinical implications were considered. The guidelines were drawn up after extensive feedback from participants and interested parties. A literature review is provided, which identifies the quality of evidence to inform the recommendations, the strength of which are based on the level of evidence. These guidelines cover the nature and detection of depressive disorders, acute treatment with antidepressant drugs, choice of drug versus alternative treatment, practical issues in prescribing and management, next-step treatment, relapse prevention, treatment of relapse, and stopping treatment.

    KW - antidepressants

    KW - depressive disorder

    KW - evidence-based guidelines

    KW - treatment

    KW - SEROTONIN-REUPTAKE INHIBITORS

    KW - PLACEBO-CONTROLLED TRIAL

    KW - RANDOMIZED CONTROLLED-TRIAL

    KW - TREATMENT-RESISTANT DEPRESSION

    KW - COGNITIVE-BEHAVIORAL THERAPY

    KW - TRANSCRANIAL MAGNETIC STIMULATION

    KW - SEASONAL AFFECTIVE-DISORDER

    KW - STAR-ASTERISK-D

    KW - VAGUS NERVE-STIMULATION

    KW - INDUCED SEXUAL DYSFUNCTION

    U2 - 10.1177/0269881107088441

    DO - 10.1177/0269881107088441

    M3 - Review article

    VL - 22

    SP - 343

    EP - 396

    JO - Journal of Psychopharmacology

    JF - Journal of Psychopharmacology

    SN - 0269-8811

    IS - 4

    ER -